Thread: l-dopa pump - NeuroDerm signs definitive investment agreements for $16 million financ
View Single Post
Old 10-25-2014, 04:42 PM
Tupelo3 Tupelo3 is offline
Member
  
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default NeuroDerm will release top-line results from phase II trial
NeuroDerm will release top-line results for ND0612L from a phase II study in patients with moderate Parkinson's patients, and preliminary interim results from a phase IIA study of ND0612H and ND0612L in advanced Parkinson's patients, at The Michael J. Fox Foundation's 2014 Parkinson's Disease Therapeutics Conference, on October 29th in New York, NY.

As Duodopa still has not yet received US FDA approval, NeuroDerm's ND0612L may make it obsolete before it ever hits the market.
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (10-29-2014), RLSmi (10-26-2014), Stand Tall (10-26-2014)